Personalized Gynecological Disease Prevention and Treatment System

A next-generation system for preventing and treating gynecological diseases using Sarcodon aspratus extracts, integrating genomic and hormonal profiling, machine learning, and wearable devices for tailored treatments and real-time monitoring.

The original patent disclosed a pharmaceutical composition for preventing or treating gynecological diseases using Sarcodon aspratus extracts. However, this approach has limitations in terms of individualization and real-time adaptation. The new inventive concept addresses these limitations by introducing a personalized and dynamic system that leverages advanced technologies to provide more effective and targeted treatments.

The system comprises a database of genomic and hormonal profiles of individuals, a machine learning model trained on the database to predict susceptibility to gynecological diseases, and a formulation generator that creates customized Sarcodon aspratus extracts-based compositions tailored to an individual's specific needs. Additionally, the system includes wearable devices and mobile applications for real-time monitoring and adjustment of Sarcodon aspratus extracts dosage. The system also features a novel Sarcodon aspratus extracts-based nanoparticle formulation for targeted delivery of active ingredients to specific gynecological tissues. Furthermore, the system includes a computer-implemented module for predicting and preventing gynecological disease onset, integrating genomic, hormonal, and lifestyle data to identify high-risk individuals and suggesting personalized health recommendations, including supplementation with Sarcodon aspratus extracts.

The new claims introduce a paradigm shift in gynecological disease prevention and treatment by integrating advanced technologies, such as machine learning, wearable devices, and nanoparticle formulations, to provide personalized and dynamic treatments. The inventive step lies in the combination of these technologies to create a tailored and adaptive system that goes beyond the limitations of the original patent.

Alternative embodiments of the system could include the use of different machine learning algorithms, various types of wearable devices, or alternative nanoparticle formulations. Additionally, the system could be adapted for use in other disease areas or expanded to include additional health recommendations and interventions.

The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, women's health, and disease prevention. The system could be marketed to healthcare providers, pharmaceutical companies, and health technology startups, offering a competitive advantage in terms of treatment outcomes and patient satisfaction.